Page last updated: 2024-08-17

cysteamine and Liver Steatosis

cysteamine has been researched along with Liver Steatosis in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (25.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (75.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Besouw, M; Levtchenko, E; Masereeuw, R; van den Heuvel, L	1
Cabrera, BL; Dohil, R; Duke, KB; Durelle, J; Lavine, JE; Schmeltzer, S; Schwimmer, JB; Wang, T	1
Cabrera, BL; Dohil, R; Lavine, JE; Meyer, L; Phillips, SA; Schmeltzer, S	1
Hathway, DE	1

Reviews

2 review(s) available for cysteamine and Liver Steatosis

Article	Year
Cysteamine: an old drug with new potential. Drug discovery today, 2013, Volume: 18, Issue:15-16 Topics: Animals; Cysteamine; Fatty Liver; Humans; Neurodegenerative Diseases; Non-alcoholic Fatty Liver Disease; Radiation-Protective Agents; Randomized Controlled Trials as Topic	2013
Chemical, biochemical and toxicological differences between carbon tetrachloride and chloroform. A critical review of recent investigations of these compounds in mammals. Arzneimittel-Forschung, 1974, Volume: 24, Issue:2 Topics: Animals; Biotransformation; Carbon Dioxide; Carbon Tetrachloride; Carcinoma, Hepatocellular; Chemical Phenomena; Chemistry; Chloroform; Cricetinae; Cysteamine; Dogs; Endoplasmic Reticulum; Fatty Liver; Haplorhini; Hydrolysis; Liver Cirrhosis; Liver Neoplasms; Mammals; Mice; Microsomes, Liver; Nephrosis; Rabbits; Rats; Structure-Activity Relationship	1974

Article

Year

Cysteamine: an old drug with new potential.

Drug discovery today, 2013, Volume: 18, Issue:15-16

Topics: Animals; Cysteamine; Fatty Liver; Humans; Neurodegenerative Diseases; Non-alcoholic Fatty Liver Disease; Radiation-Protective Agents; Randomized Controlled Trials as Topic

2013

Chemical, biochemical and toxicological differences between carbon tetrachloride and chloroform. A critical review of recent investigations of these compounds in mammals.

Arzneimittel-Forschung, 1974, Volume: 24, Issue:2

Topics: Animals; Biotransformation; Carbon Dioxide; Carbon Tetrachloride; Carcinoma, Hepatocellular; Chemical Phenomena; Chemistry; Chloroform; Cricetinae; Cysteamine; Dogs; Endoplasmic Reticulum; Fatty Liver; Haplorhini; Hydrolysis; Liver Cirrhosis; Liver Neoplasms; Mammals; Mice; Microsomes, Liver; Nephrosis; Rabbits; Rats; Structure-Activity Relationship

1974

Other Studies

2 other study(ies) available for cysteamine and Liver Steatosis

Article	Year
Enteric-coated cysteamine for the treatment of paediatric non-alcoholic fatty liver disease. Alimentary pharmacology & therapeutics, 2011, Volume: 33, Issue:9 Topics: Adiponectin; Adolescent; Antioxidants; Body Mass Index; Body Weight; Child; Cysteamine; Fatty Liver; Female; Humans; Insulin Resistance; Male; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Pilot Projects; Tablets, Enteric-Coated; Transaminases; Treatment Outcome	2011
The effect of cysteamine bitartrate on adiponectin multimerization in non-alcoholic fatty liver disease and healthy subjects. The Journal of pediatrics, 2012, Volume: 161, Issue:4 Topics: Adiponectin; Antioxidants; Child; Cysteamine; Dose-Response Relationship, Drug; Electrophoresis, Gel, Two-Dimensional; Fatty Liver; Humans; Non-alcoholic Fatty Liver Disease; Protein Multimerization	2012

Article

Year

Enteric-coated cysteamine for the treatment of paediatric non-alcoholic fatty liver disease.

Alimentary pharmacology & therapeutics, 2011, Volume: 33, Issue:9

Topics: Adiponectin; Adolescent; Antioxidants; Body Mass Index; Body Weight; Child; Cysteamine; Fatty Liver; Female; Humans; Insulin Resistance; Male; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Pilot Projects; Tablets, Enteric-Coated; Transaminases; Treatment Outcome

2011

The effect of cysteamine bitartrate on adiponectin multimerization in non-alcoholic fatty liver disease and healthy subjects.

The Journal of pediatrics, 2012, Volume: 161, Issue:4

Topics: Adiponectin; Antioxidants; Child; Cysteamine; Dose-Response Relationship, Drug; Electrophoresis, Gel, Two-Dimensional; Fatty Liver; Humans; Non-alcoholic Fatty Liver Disease; Protein Multimerization

2012